Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CLEC4A encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Additionally we are shipping C-Type Lectin Domain Family 4, Member A Proteins (6) and C-Type Lectin Domain Family 4, Member A Kits (1) and many more products for this protein.
Showing 10 out of 72 products:
Human Polyclonal CLEC4A Primary Antibody for ELISA - ABIN1998787
Wakefield, Lloyd: The role of cytokines in the pathogenesis of inflammatory eye disease. in Cytokine 1992
Show all 4 references for 1998787
Human Monoclonal CLEC4A Primary Antibody for ELISA, ELISA (Detection) - ABIN1998777
Kanazawa, Tashiro, Miyachi: Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. in Immunobiology 2004
Show all 4 references for 1998777
Human Monoclonal CLEC4A Primary Antibody for ELISA, FACS - ABIN1998779
Fujikado, Saijo, Yonezawa, Shimamori, Ishii, Sugai, Kotaki, Sudo, Nose, Iwakura: Dcir deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. in Nature medicine 2008
Show all 4 references for 1998779
Human Monoclonal CLEC4A Primary Antibody for ELISA - ABIN1998785
Lambert, Gilbert, Richard, Beaulieu, Tremblay: The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans- and cis-infection pathways. in Blood 2008
Show all 4 references for 1998785
Human Monoclonal CLEC4A Primary Antibody for FACS, WB - ABIN4900472
Meyer-Wentrup, Benitez-Ribas, Tacken, Punt, Figdor, de Vries, Adema: Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. in Blood 2008
Show all 3 references for 4900472
Human Monoclonal CLEC4A Primary Antibody for FACS - ABIN4897764
Llinàs, Lázaro, de Salort, Matesanz-Isabel, Sintes, Engel: Expression profiles of novel cell surface molecules on B-cell subsets and plasma cells as analyzed by flow cytometry. in Immunology letters 2010
DCIR SNP rs2377422 is a novel genetic susceptibility factor for both SLE and primary SS.
this study shows that sulfo-Lewis(a) is a high affinity ligand for DCIR and that DCIR interacts with ligands from both pathogenic and endogenous origin of which most are shared by DC-SIGN (show CD209 Antibodies).
No association was found between our inflammatory bowel disease cohort and the candidate single nucleotide polymorphisms for DCIR (CD/HC: P=0.22 and UC/HC: P=0.41)
Data provide evidence for association between DCIR rs2377422 and RA in non-Caucasian populations and confirm the influence of DCIR polymorphisms on RA susceptibility, especially on ACPA (show PRTN3 Antibodies)-negative RA.
An involvement of ITIM domain in HIV-1-mediated signaling events and a relationship between phosphorylation events and DCIR function with respect to HIV-1 biology.
Data show that antigen targeting via the DCIR receptor allows activation of specific CD8 (show CD8A Antibodies)(+) T-cell immunity.
CLECSF6 is involved in the control of inflammation in neutrophils
The phosphorylation of SHP-2 (show PTPN11 Antibodies) by GM-CSF (show CSF2 Antibodies) promotes the binding of SHP-2 (show PTPN11 Antibodies) to the GM-CSF (show CSF2 Antibodies) receptor to the disadvantage of CLECSF6.
Human APLEC and DCIR may be associated with susceptibility to anti-CCP (show CRYGD Antibodies)-negative rheumatoid arthritis.
The data show that targeting of DCIR can modulate human plasmacytoid dendritic cell function and may be applied in disease prevention and treatment.
this study shows that upon injection of d-galactosamine and lipopolysaccharide, Dcir1-/- mice show decreased mortality rates and serum levels of alanine aminotransferase (show ALT Antibodies)
Dcir1 enhances the pathogenesis of DSS (show PMP22 Antibodies) colitis by altering neutrophil recruitment and their functions.
While DCIR1 was ubiquitously expressed on myeloid cells in various immune organs, significant expression of DCAR2 was detected only on subpopulations of conventional dendritic cells from bone marrow and skin-draining lymph nodes.
MCL (show CLEC4D Antibodies)-/- as well as DCIR-/- mice exhibited only a slightly increased severity of disease compared to wild-type mice indicating a limited role for MCL (show CLEC4D Antibodies) and DCIR in the regulation of intestinal immunity.
our findings show that DCIR plays an important role in maintaining bone homeostasis.
DCIR is a novel receptor for IVIg, mediating interaction of innate and adaptive immunity in tolerogenic responses.
This study indicates that DCIR is critically involved in Cerebral malaria induction
These results suggest that DCIR plays a protective role in limiting the Chikungunya virus-induced inflammatory response and subsequent tissue and joint damage.
These observations indicate that Dcir is a negative regulator of dendritic cell expansion and has a crucial role in maintaining the homeostasis of the immune system.
This gene encodes a member of the C-type lectin/C-type lectin-like domain (CTL/CTLD) superfamily. Members of this family share a common protein fold and have diverse functions, such as cell adhesion, cell-cell signalling, glycoprotein turnover, and roles in inflammation and immune response. The encoded type 2 transmembrane protein may play a role in inflammatory and immune response. Multiple transcript variants encoding distinct isoforms have been identified for this gene. This gene is closely linked to other CTL/CTLD superfamily members on chromosome 12p13 in the natural killer gene complex region.
C-type lectin domain family 4, member A
, C-type lectin, superfamily member 6
, C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 6
, C-type lectin DDB27
, C-type lectin domain family 4 member A
, C-type lectin superfamily member 6
, dendritic cell immunoreceptor
, lectin-like immunoreceptor
, C-type (calcium dependent, carbohydrate recognition domain) lectin, superfamily member 6
, dendritic cell inhibitory receptor 1